These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11277528)

  • 1. Spatial requirements of the antagonist binding site of the NK2 receptor.
    Ali MA; Bhogal N; Fishwick CW; Findlay JB
    Bioorg Med Chem Lett; 2001 Mar; 11(6):819-22. PubMed ID: 11277528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
    Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
    Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New spiropiperidines as potent and selective non-peptide tachykinin NK2 receptor antagonists.
    Smith PW; Cooper AW; Bell R; Beresford IJ; Gore PM; McElroy AB; Pritchard JM; Saez V; Taylor NR; Sheldrick RL
    J Med Chem; 1995 Sep; 38(19):3772-9. PubMed ID: 7562907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist.
    Emonds-Alt X; Advenier C; Cognon C; Croci T; Daoui S; Ducoux JP; Landi M; Naline E; Neliat G; Poncelet M; Proietto V; Van Broeck D; Vilain P; Soubrié P; Le Fur G; Maffrand JP; Brelière JC
    Neuropeptides; 1997 Oct; 31(5):449-58. PubMed ID: 9413022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
    Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA
    J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the proximity of the extreme N-terminus of the neurokinin-2 (NK2) tachykinin receptor to Cys167 in the putative fourth transmembrane helix.
    Bhogal N; Blaney FE; Ingley PM; Rees J; Findlay JB
    Biochemistry; 2004 Mar; 43(11):3027-38. PubMed ID: 15023054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
    Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
    J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat.
    Steinberg R; Marco N; Voutsinos B; Bensaid M; Rodier D; Souilhac J; Alonso R; Oury-Donat F; Le Fur G; Soubrie P
    Eur J Neurosci; 1998 Jul; 10(7):2337-45. PubMed ID: 9749762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors.
    Beresford IJ; Sheldrick RL; Ball DI; Turpin MP; Walsh DM; Hawcock AB; Coleman RA; Hagan RM; Tyers MB
    Eur J Pharmacol; 1995 Jan; 272(2-3):241-8. PubMed ID: 7713168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spiro-substituted piperidines as neurokinin receptor antagonists. III. Synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and evaluation of NK1-NK2 dual antagonistic activities.
    Kubota H; Kakefuda A; Okamoto Y; Fujii M; Yamamoto O; Yamagiwa Y; Orita M; Ikeda K; Takeuchi M; Shibanuma T; Isomura Y
    Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1538-44. PubMed ID: 9810691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Alkylpiperidines related to SR-48968: potent antagonists of the neurokinin-2 (NK2) receptor.
    Jacobs RT; Shenvi AB; Mauger RC; Ulatowski TG; Aharony D; Buckner CK
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1935-40. PubMed ID: 9873462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design and synthesis of novel NK1/NK2 dual antagonists.
    Reichard GA; Ball ZT; Aslanian R; Anthes JC; Shih NY; Piwinski JJ
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2329-32. PubMed ID: 11055349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterisation of tachykinin receptors mediating ion transport in porcine jejunum.
    Thorbøll JE; Bindslev N; Hansen MB; Schmidt P; Skadhauge E
    Eur J Pharmacol; 1998 Oct; 359(2-3):271-9. PubMed ID: 9832399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of both NK1 and NK2 receptors in guinea-pig airways.
    McKee KT; Millar L; Rodger IW; Metters KM
    Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachykinin NK2 receptors: characterization in the rat small intestine by the use of a peptide agonist and a nonpeptide antagonist as radioligands.
    Renzetti AR; Criscuoli M; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):139-44. PubMed ID: 9228201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites.
    Turcatti G; Nemeth K; Edgerton MD; Meseth U; Talabot F; Peitsch M; Knowles J; Vogel H; Chollet A
    J Biol Chem; 1996 Aug; 271(33):19991-8. PubMed ID: 8702716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of tachykinin NK2 receptor on dog proximal colon. Antagonism by MEN 10,627 and SR 48,968.
    Parlani M; Conte B; Cirillo R; Manzini S
    Eur J Pharmacol; 1996 Dec; 318(2-3):419-24. PubMed ID: 9016933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted approach to determine the antagonist molecular mechanism and interaction of ibodutant ([1-(2-phenyl-1R-[[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl]-ethylcarbamoyl)-cyclopentyl]-amide) at the human tachykinin NK2 receptor.
    Meini S; Bellucci F; Catalani C; Cucchi P; Giolitti A; Santicioli P; Giuliani S
    J Pharmacol Exp Ther; 2009 May; 329(2):486-95. PubMed ID: 19218528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.